|
|
|
|
|
| Li,Jingjing; Xiong,Ying; Sun,Shimin; Yu,Lehan; Huang,Chunhong. |
| Abstract Background: The gamma-type phospholipase A2 inhibitor (ΡLIγ) is a natural protein commonly found in snake serum, which can neutralize pathophysiological effects of snake venom phospholipases A2. Therefore, this protein is a potential candidate to the development of a novel antivenom. To the best of our knowledge, there is no antibody currently available for PLIγ identification and characterization. Methods: Bioinformatics prediction of epitope using DNAStar software was performed based on the sequence of Sinonatrix annularis PLIγ (SaPLIγ). The best epitope 151CPVLRLSNRTHEANRNDLIKVA172 was chosen and synthesized, and then conjugated to keyhole limpet hemocyanin and bovine serum albumin for use as an immunogen and plate-coating antigen,... |
| Tipo: Info:eu-repo/semantics/article |
Palavras-chave: Monoclonal antibody; Phospholipase A2 inhibitor; Epitope prediction. |
| Ano: 2017 |
URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992017000100314 |
| |
|
|
| Zhang,Jingmin; Wang,Yafeng; Peng,Youmei; Qin,Chongzhen; Liu,Yixian; Li,Jingjing; Jiang,Jinhua; Zhou,Yubing; Chang,Junbiao; Wang,Qingduan. |
| ABSTRACT Antiviral drug resistance is the most important factor contributing to treatment failure using nucleos(t)ide analogs such as lamivudine for chronic infection with hepatitis B virus (HBV). Development of a system supporting efficient replication of clinically resistant HBV strains is imperative, and new antiviral drugs are needed urgently to prevent selection of drug-resistant HBV mutants. A novel fluorinated cytidine analog, NCC (N-cyclopropyl-4′-azido-2′-deoxy-2′-fluoro-β-d-cytidine), was recently shown to strongly inhibit human HBV in vitro and in vivo. This study was designed to evaluate the antiviral activity of NCC against lamivudine-resistant HBV. We generated a stable cell line encoding the major pattern of lamivudine-resistant mutations... |
| Tipo: Info:eu-repo/semantics/article |
Palavras-chave: N-cyclopropyl-4′-azido-2′-deoxy-2′-fluoro-β-D- cytidine; Hepatitis B virus; HepG2.RL1 cells; Lamivudine-resistant; RtL180M/M204V. |
| Ano: 2018 |
URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000600477 |
| |
|
|
|
